- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06305052
Effects of Olfactory and Gustatory Stimulus on the Nutrition of Premature Babies
Effects of Olfactory and Gustatory Stimulus on the Nutrition of Premature Babies: Double-blind Randomized Clinical Trial
The objective of this clinical trial is to test the effects of olfactory and taste stimulation with milk or water in premature newborns with a gestational age between 28 and 32 weeks.
The main question researchers want to resolve is: • Does olfactory and gustatory stimulation in these newborns reduce the time spent with an oral or nasogastric feeding tube and bring forward oral feeding? Participants will be stimulated with milk or water depending on the randomly chosen group. 1: the olfactory stimulus (with smell) will be performed with a sterile cotton swab close to the nostrils immediately before feeding through the tube, 2: the gustatory stimulus (taste) will be performed with a sterile cotton swab on which a drop of milk or water will be applied on the newborn's tongue if they are awake or on their lips if they are sleeping, and is performed immediately before tube feeding.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this clinical trial is to test the effects of olfactory and taste stimulation with milk or water in premature newborns with a gestational age between 28 and 32 weeks.
Prematurity is the main cause of infant morbidity and mortality in Brazil. Nutritional problems caused by digestive immaturity are generally associated with undesirable outcomes in preterm infants, both immediate and late, and improving preemies' tolerance to milk has been challenging. The cephalic phase of digestion plays a crucial role in nutrient absorption. However, although it is known that smell and taste develop during intrauterine life, olfactory and taste stimuli have not yet been properly studied in the nutrition of premature babies. Objectives: to determine the effects of olfactory and gustatory stimuli on the nutrition of premature infants admitted to the neonatal intensive care unit of the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP).Methods: a double-blind randomized clinical trial will be carried out in premature infants receiving enteral feeding via an oro/nasogastric tube. The study will be carried out at the IMIP university hospital, Recife-Pernambuco. The population will be composed of premature babies with a gestational age between 28 and 32 weeks and/or weighing < or equal to 1,500g and who are indicated for feeding through a naso/orogastric tube. The intervention will consist of olfactory and taste stimuli through breast milk. The primary outcome will be considered the period defined in days from the beginning of stimulation until the removal of the nasal or orogastric tube. Secondary outcomes will be considered: weight gain and anthropometric parameters, such as weight, length and head circumference at discharge from the NICU, as well as feeding time via oral/nasal and parenteral gastric tube, type of feeding at the time of secretion (natural or artificial) and diagnosis of necrotizing enterocolitis. The study is characterized as a prospective randomized clinical trial, with a pragmatic sample size determined during the recruitment period established at 10 months. Analysis will be performed by intention to treat. This project must be previously approved by the IMIP Ethics Committee and all participants must have their parents sign the Free and Informed Consent Form
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 50070-550
- Instituto de Medicina Integral Professor Fernando Figueira
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Newborns with Gestational Age (GA) between 28 and 32 weeks and/or birth weight ≤1,500g.
- Use of oro/nasogastric tube.
Exclusion Criteria:
- Newborns who have already started enteral feeding
- Twin newborns
- Congenital malformation associated with the digestive system that requires surgery soon after birth.
- Congenital conditions that impair growth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Milk group
Olfactory and gustatory stimuli with milk in premature infants before tube feeding.
|
Premature newborns allocated to the intervention group will receive olfactory and taste stimuli immediately before feeding through an oral/nasal gastric tube. In the intervention group, the taste stimulus will be carried out through a drop of milk administered directly to the tongue of the premature baby if he is awake, if the newborn is sleeping the milk will be placed on his lips. The olfactory stimulus will be offered through a drop of milk using a cotton swab, positioned close to the premature baby's nostrils as close as possible without touching them, immediately before the tube diet. |
|
Placebo Comparator: Placebo group
Olfactory and taste stimuli with double-distilled water in premature infants before tube feeding
|
In the control group, the taste stimulus will be done through a drop of double-distilled water on a cotton swab, then administered directly to the tongue of the premature baby if he is awake, however, when he is sleeping, the drop of water will be deposited on his lips.
The olfactory stimulus in the control group will be carried out with a drop of double-distilled water using a cotton swab, positioned close to the nostrils as close as possible without touching them, immediately before carrying out the tube diet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the period between the beginning of the intervention and enteral feeding.
Time Frame: until the moment when the newborn's oral or nasal gastric tube will be removed (evaluated up to 1 month).
|
Comparison of the period between the beginning of the intervention and the completion of enteral feeding (removal of the oral or nasogastric tube), verified through the number of days in the period.
will be verified in the newborn's medical record.
|
until the moment when the newborn's oral or nasal gastric tube will be removed (evaluated up to 1 month).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Describe the gestational age of the newborn
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
This information will be collected from the newborn's medical record.
Data regarding the gestational age of the newborn will be expressed in weeks.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Describe the sex of the newborn.
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
This information will be collected from the newborn's medical record.
Data regarding the sex of the newborn will be expressed as female or male.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Describe the type of birth.
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
This information will be collected from the newborn's medical record.
Data regarding the type of birth will be expressed as vaginal or cesarean section.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Describe the APGAR score.
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
This information will be collected from the newborn's medical record.
The data regarding the APGAR score will be expressed in positive natural numbers from 0 to 10 in the first and fifth minutes of the newborn's life.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Describe birth weight and birth weight z-score.
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
The data will initially be checked in the medical record to obtain anthropometric parameters at birth: weight will be expressed in grams.
The data obtained will be used in the Fenton 2013 calculator tool to obtain the zscores.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Describe head circumference at birth and head circumference z-score at birth
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
The data will initially be checked in the medical record to obtain anthropometric parameters at birth: the head circumference will be expressed in centimeters.
The data will then be used in the Fenton 2013 calculator tool to obtain zscores.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Describe birth length and birth length z-score.
Time Frame: until the moment of data collection from the medical records, which is equivalent to 1 day.
|
The data will initially be checked in the medical record to obtain anthropometric parameters at birth: length will be expressed in centimeters.
The data will then be used in the Fenton 2013 calculator tool to obtain the zscores.
|
until the moment of data collection from the medical records, which is equivalent to 1 day.
|
|
Determine the frequency of rupture of membranes >24h, chorioamnionitis, antepartum hemorrhage, gestational hypertension, pre-eclampsia and prenatal steroids >24h.
Time Frame: at the time of data collection from the medical record, which is equivalent to 1 day.
|
This information will be collected from the newborn's medical record.
They will be noted on a specific form created by the researchers to demonstrate, through alternatives between yes or no, the presence of these variables.
|
at the time of data collection from the medical record, which is equivalent to 1 day.
|
|
Compare the time, in days, of feeding via oral/nasal gastric tube.
Time Frame: until the moment the tube feeding time will be recorded in days (evaluated up to 2 months).
|
The number of days that the newborn was fed through a tube will be recorded, using data provided in the medical record.
|
until the moment the tube feeding time will be recorded in days (evaluated up to 2 months).
|
|
Compare the total duration, in days, of parenteral nutrition (TPN) use.
Time Frame: until the moment the time of parenteral nutrition feeding will be recorded in days (evaluated up to 15 days).
|
The number of days that the newborn was fed by parenteral nutrition will be recorded, using data provided in the medical record.
|
until the moment the time of parenteral nutrition feeding will be recorded in days (evaluated up to 15 days).
|
|
Compare the type of food at discharge (natural, artificial or mixed).
Time Frame: until the moment when the type of food offered to the newborn upon discharge will be recorded (evaluated within 2 months).
|
The type of food that the newborn received during hospital discharge will be presented, whether it was natural with breast milk, artificial with the use of milk formulas or mixed when premature, it received both types of food.
They will be obtained through data in the medical record.
|
until the moment when the type of food offered to the newborn upon discharge will be recorded (evaluated within 2 months).
|
|
Compare weight gain and weight Z score, at 28 days of life and at discharge from the neonatal ICU, as well as anthropometric parameters: head circumference and length with their respective Z score at discharge from the NICU.
Time Frame: until the newborn is 28 days old (assessed until the 28th) and at discharge (up to 2 months)
|
The data will initially be checked in the medical record to obtain anthropometric parameters: weight in grams, length in centimeters and head circumference in centimeters.
The data will then be used in the Fenton 2013 calculator tool to obtain zscores.
|
until the newborn is 28 days old (assessed until the 28th) and at discharge (up to 2 months)
|
|
Compare gestational age (GA) at the time of removal of the oro/nasogastric tube and at discharge from the NICU.
Time Frame: until removal of the newborn's tube (assessed up to 2 months) and at discharge (up to 2 months)
|
The gestational age data referring to the moment the newborn's tube was removed and at the time of discharge will be expressed in weeks.
This data will be collected from the medical record.
|
until removal of the newborn's tube (assessed up to 2 months) and at discharge (up to 2 months)
|
|
Compare the frequency of diagnosis of patent ductus arteriosus requiring treatment, bronchopulmonary dysplasia (BPD), retinopathy of prematurity, intraventricular hemorrhage and necrotizing enterocolitis.
Time Frame: until the moment of discharge of the newborn (evaluated up to 2 months).
|
This information will be collected from the newborn's medical record.
They will be noted on a specific form prepared by the researchers to demonstrate, through alternatives between yes or no, the presence of these variables.
|
until the moment of discharge of the newborn (evaluated up to 2 months).
|
|
Determine the association of treatment time with oxygen therapy (nasal catheter, nasal prong - nasal CPAP, intermittent positive pressure or endotracheal ventilation) in hours.
Time Frame: until the moment of discharge of the newborn (assessed up to 2 months).
|
The medical record will check the treatment time in days, the treatment with oxygen therapy, whether it be (nasal catheter, nasal prong - nasal CPAP, intermittent positive pressure or endotracheal ventilation).
After obtaining this data, the time will be transformed into hours and recorded on a specific research form.
|
until the moment of discharge of the newborn (assessed up to 2 months).
|
Collaborators and Investigators
Investigators
- Study Director: João GB Alves, PhD, Instituto de Medicina Integral Fernando Figueira IMIP
- Principal Investigator: Luana GR Fonseca, Instituto de Medicina Integral Fernando Figueira IMIP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- estimulation-taste-olfactory
- 65635922.0.0000.5201 (Other Identifier: CAAE (Certificate of Presentation of Ethical Review))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
-
Elgan Pharma Ltd.Terminated
-
Hôpital de la Croix-RousseUnknownPremature Birth of NewbornFrance
Clinical Trials on Milk
-
University of ReadingCompletedMilk IntoleranceUnited Kingdom
-
University of OxfordNational Institute for Health Research, United KingdomCompletedPremature Birth | Necrotizing Enterocolitis | Late-onset Invasive InfectionUnited Kingdom, Ireland
-
Maastricht University Medical CenterDutch Dairy Association (NZO)CompletedInflammation | Atherosclerosis | HyperlipidemiasNetherlands
-
Hospital Universitario San IgnacioCompleted
-
Laura KairThe Gerber Foundation; Children's Miracle NetworkCompletedExclusive Breastfeeding | Breastfeeding Duration | Donor Milk SupplementationUnited States
-
University of California, San FranciscoRecruitingHeart Diseases | Cardiovascular DiseaseUnited States
-
Boston Children's HospitalRecruitingCardiovascular Diseases | Obesity | DiabetesUnited States
-
University of Veterinary and Animal Sciences, Lahore...University of Education, Lahore; Friesland campina Engro PakistanCompletedMilk Intervention on Body Composition and School AttendancePakistan
-
NIZO Food ResearchFrieslandCampinaCompleted
-
Uppsala UniversityForteCompletedInflammation | Oxidative StressSweden